Mithomycin – C in the prevention of tracheal restenoses

D. Mrad, M. Diaz, J. Rolleri (Buenos Aires, Argentina)

Source: Annual Congress 2004 - New developments in endobronchial treatment
Session: New developments in endobronchial treatment
Session type: Oral Presentation
Number: 4295
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

OBJECTIVE : to evaluate the use of topical mithomycin-C ( Mit-C ) in the prevention of tracheal restenoses.DESIGN: prospective, experimental, longitudinal. PATIENT SELECTION : patients presenting with benign tracheal stenoses.TIME : march 2001 – july 2003. DEFINITIONS : The procedure was considered succesful if the patient presented resolution of symptoms and endoscopic improvement, partial success if one of the two aspects was achieved, and failure the persistence of symptoms and stenoses. PROCEDURES : Tracheal stenoses was treated with laser o mechanical dilatation. Mit-C was applied topically ( 0.25mgr/ml. ) during 5 minutes. Patients were treated with antibiotics for seven days and budesonide 1600 mcgr/ day for three months. RESULTS : Eight patients were included , mean age of 35.8 years ( 17 – 56 ). Tracheal stenoses was secondary to tracheal intubation ( 7 patients ) and Wegeners Granulomatosis. Lesions had a mean length of 3.8 cms ( 1.5 - 6 cms ), and mean diameter was 5.1 mm ( 4 – 9 mm ); they had been present for 1 – 48 months ( mean 24.3 months ). In five patients the use of Mit-C was succesful, achieving symptom control, lesion stability and allowing the removal of stents in two cases. Patients remained asymptomatic for over a year ( mean follow up 14.5 months ). Three patients presented airway restenoses.CONCLUSIONS: The use of Mit - C can mantain airway patency after laser or mechanical dilation and achieve lesion stability, preventing restenoses or the need for stent placement, especially in patients who are unable to undergo surgery. Further studies are needed to draw definitive conclusions on its use.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Mrad, M. Diaz, J. Rolleri (Buenos Aires, Argentina). Mithomycin – C in the prevention of tracheal restenoses. Eur Respir J 2004; 24: Suppl. 48, 4295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The natural stent in the management of post-intubation tracheal stenosis
Source: Annual Congress 2009 - Stents, needles and sedation
Year: 2009


The role of tracheal stenting in the alternative treatment of tracheal stenosis
Source: Eur Respir J 2006; 28: Suppl. 50, 276s
Year: 2006

Silicone stenting for postintubation tracheal stenoses
Source: Eur Respir J 2002; 20: Suppl. 38, 616s
Year: 2002

The effects of nitinol stent on the severe tracheobronchial stenoses and the comparison of different insertions
Source: Eur Respir J 2002; 20: Suppl. 38, 616s
Year: 2002

Surgical treatment for cicatricial cervical tracheal stenoses
Source: Eur Respir J 2002; 20: Suppl. 38, 152s
Year: 2002

Use of silicone stents for the management of post-tuberculosis tracheobronchial stenosis
Source: Eur Respir J 2006; 28: 1029-1035
Year: 2006



Is endobronchial management of tracheal stenosis a viable alternative to tracheal surgery for selected patients?
Source: Annual Congress 2008 - Trends in interventional pulmonology
Year: 2008


Clinical benefits and complications of Dumon stent insertion to severe central airway stenosis or airway fistula from seven year experiences
Source: Eur Respir J 2006; 28: Suppl. 50, 515s
Year: 2006

Non-anastomostic bronchial stenoses after lung transplantation: outcome of endobronchial stent placement
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006

The effect of topical mitomycin C on the site of tracheal stenosis after dilatation
Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy
Year: 2010


Functional benefit of dumon stent placement in patients with tracheobronchial stenoses
Source: Eur Respir J 2001; 18: Suppl. 33, 393s
Year: 2001

Tracheal stenosis in patients with a long-term tracheostomy
Source: Eur Respir J 2006; 28: Suppl. 50, 595s
Year: 2006

Effects of the tracheal dilation in benign tracheal stenosis
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001

Features and management of iatrogenic tracheal stenosis
Source: International Congress 2018 – Pleural effusions, infections and tumours
Year: 2018


Surgical treatment of benign tracheal stenoses
Source: Eur Respir J 2005; 26: Suppl. 49, 632s
Year: 2005

Tracheal stenosis – treatment algorithms
Source: ERS Skills Course 2016
Year: 2016

Tracheobronchial stents allow extubation in ventilator dependent patients due to benign central airway stenosis
Source: Eur Respir J 2004; 24: Suppl. 48, 93s
Year: 2004

Surgical treatment of tracheal stenosis
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008


Current problems in surgical treatment of cicatritial tracheal stenosis
Source: Annual Congress 2007 - Airway problems: surgical and endoscopic solutions
Year: 2007


Successful treatment of benign tracheal stenosis with bronchoscopy cryotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 533s
Year: 2005